678
Views
44
CrossRef citations to date
0
Altmetric
Review

Therapeutic contact lenses: a patent review

, , , , &

Bibliography

  • Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev 1995;16:39-43
  • Gaudana R, Ananthula HK, Parenky A, et al. Ocular drug delivery. AAPS J 2010;12:348-60
  • Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 1982;26:207-18
  • Norell SE. Improving medication compliance: A randomised clinical trial. BMJ 1979;2:1031-3
  • Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477-80
  • Li C, Chauhan A. Modeling ophthalmic drug delivery by soaked contact lenses. Ind Eng Chem Res 2006;45:3718-34
  • Peng C, Burke MT, Carbia BE, et al. Extended drug delivery by contact lenses for glaucoma therapy. J Controlled Release 2012;162(1):152-8
  • Peng C, Ben-Shlomo A, Mackay EO, et al. Drug delivery by contact lens in spontaneously glaucomatous dogs. Curr Eye Res 2012;37:204-11
  • Jung HJ, Abou-Jaoude M, Carbia BE, et al. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses. J Controlled Release 2013;165:82-9
  • Maurice DM, Mishima S. Ocular pharmacokinetics. In: Sears ML, editor. Pharmacology of the eye. Springer Berlin Heidelberg, Geissen, Germany; 1984. p. 19-116
  • Ahmed PTF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Vis Sci 1985;26:584-7
  • Achouri D, Alhanout K, Piccerelle P, et al. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2012;1-19
  • Saarinen-Savolainen P, Jarvinen T, Araki-Sasaki K, et al. Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line. Pharmaceut Res 1998;15:1275-80
  • Baudouin C, Labbé A, Liang H, et al. Preservatives in eyedrops: The good, the bad and the ugly. Prog Retin Eye Res 2010;29:312-34
  • Jaenen N, Baudouin C, Pouliquen P, et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 2007;17:341-9
  • Pisella PJ, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002;86:418-23
  • Wichterle O, Lim D. Cross-linked hydrophilic polymers and articles made therefrom. USA 1965;3(220):960
  • Sedlavek J. Possiblities of application of ophthalmic drugs with the aid of gel contact lens. Cesk Oftalmol 1965;21:509-14
  • Jain MR, Batra V. Steroid pentetration in human aqueous with ’sauflon 70’ lenses. Indian J Ophthalmol 1979;27:26-31
  • Hillman JS. Management of acute glaucoma with pilocarpine-soaked hydrophilic lens. Br J Ophthalmol 1974;58:674-9
  • Ramer RM, Gasset AR. Ocular penetaration of pilocarpine: The effect of hydrophilic soft contact lenses on the ocular penetration of pilocarpine. Ann Ophthalmol 1974;6:1325-7
  • Hillman JS, Marsters JB, Broad A. Pilocarpine delivery by hydrophilic lens in the management of acute glaucoma. Trans Ophthalmol Soc UK 1975;95:79-84
  • Bietti G, Virno M, Pecori-giraldi J, et al. Possibility of isoproterenol therapy with soft contact lenses: Ocular hypotension without systemic effects. Ann Ophthalmol 1976;8:819-22
  • Ruben M, Watkins R. Pilocarpine dispensation for the soft hydrophilic contact lens. Br J Ophthalmol 1975;59:455-8
  • Marmion VJ, Yurdakul S. Pilocarpine administartion by contact lens. T Ophthal Soc UK 1977;97:162-3
  • Rosenwald P; inventor. Occular device. USA 1984;4(494):922
  • Neefe C; inventor. Non-optical corneal drug delivery. USA 1986;4(592):752
  • Knepper P; inventor. Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension. USA 1986;4(617):299
  • Bawa R; inventor. Bausch & Lomb Incorporated, assignee. Sustained-release formulation containing and amino acid polymer. USA 1987;4(668):506
  • Schultz C, Nunez I, Silor D, et al. inventors. Johnson and Johnson Vision Products, Inc, assignee. Contact lens containing a leachable absorbed material. USA 1998;5(723):131
  • Schwartz B; inventor. New England Medical Center Hospital, Inc, assignee. Method of and solution for treating glaucoma. USA 1993;5(212):168
  • Bachmann F, Lohmann D, Chabrecek P; inventorsNovartis AG. Poly-unsaturated carbohydrate derivatives, polymers thereof and their use. USA 1999;5(939):466
  • Nakada K, Sugiyama A; inventorsMenicon CL. Process for producing controlled drug-release contact lens, and controlled drug-release contact lens thereby produced. Japan 2000;6(027):745
  • Karlgard CC, Wong NS, Jones LW, et al. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials. Int J Pharm 2003;257:141-51
  • Wulff G, Sarhan A. Use of polymers with enzyme-analogous structures for resolution of racemates. Angew Chem Int Ed Engl 1972;11:33-4
  • Sellergren B, Allender CJ. Molecularly imprinted polymers: A bridge to advanced drug delivery. Adv Drug Deliv Rev 2005;57:1733-41
  • Alvarez-Lorenzo C, Concheiro A. Molecularly imprinted polymers for drug delivery. J Chromat B 2004;804:231-45
  • Cunliffe D, Kirby A, Alexander C. Molecularly imprinted drug delivery systems. Adv Drug Deliv Rev 2005;57:1836-53
  • Peppas N, Durgam A; inventors. Board of regents, the university of texas system, assignee. hihgly porous, recognitive polymer systems. USA 2014;8(741):316
  • Peppas N, Ekerdt B, Gomez-Burgaz M; inventors. Board of Regents, The University of Texas System, assignee. Method and process for the production of multi-coated recognitive and releasing systems. USA 2014;8(821):899
  • Byrne M, Venkatesh S; inventors. Auburn University, assignee. Contact drug delivery system. USA 2013;8(404):271
  • Byrne ME. Auburn University, assignee. Therapeutic contact lenses with anti-fungal delivery. USA 2013;8(349):352
  • Maryam A, Byrne M. Auburn University, assignee. Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform. USA 2013;8(388):995
  • Gulsen D, Li C, Chauhan A. Dispersion of DMPC liposomes in contact lenses for ophthalmic drug delivery. Curr Eye Res 2005;30:1071-80
  • Chauhan A, Gulsen D; inventors. University of Florida Research Foundation, Incorporated, assignee. Ophthalmic drug delivery system. USA 2009;7(638):137
  • Chauhan A, Gulsen D. University of florida research foundation, incorporated, assignee. ophthalmic drug delivery system. USA 2012;8(273):366
  • Chauhan A, Gulsen Onbilger D, Kapoor Y, et al. University of florida research foundation, incorporated, assignee. dispersions of microemulsions in hydrogels for drug delivery. USA 2011;8(071):121
  • Gulsen D, Chauhan A. Dispersion of microemulsion drops in HEMA hydrogel: A potential ophthalmic drug delivery vehicle. Int J Pharm 2005;292:95-117
  • Jung HJ, Chauhan A. Temperature sensitive contact lenses for triggered ophthalmic drug delivery. Biomaterials 2012;33:2289-300
  • Chauhan A, Jung H, Gause S; inventors. University of Florida Research Foundation, Incorporated, assignee. UV blocker loaded contact lens. USA 2014
  • Liu D, Liu P. National chiao tung university, assignee. drug-carrying contact lens and method for fabricating the same. USA 2014;8(623):400
  • Danion A, Brochu H, Martin Y, et al. Fabrication and characterization of contact lenses bearing surface-immobilized layers of intact liposomes. J Biomed Mater Res A 2007;82:41-51
  • Lally J, Kotov N; inventorsNovartis AG. Materials containing multiple layers of vesicles. USA 2008;7(329):415
  • Lally J, Kotov N; inventorsNovartis AG. Materials containing multiple layers of vesicles. USA 2011;7(901):706
  • Danion A, Arsenault I, Vermette P. Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin. J Pharm Sci 2007;96:2350-63
  • Qiu Y, Newton S, Pruitt J, et al.Novartis AG. Silicone hydrogel lens with a crosslinked hydrophilic coating. USA 2015;8(944):592
  • Li J, Zhang Z, Loose C, et al. Semprus Bioscience corporation, assignee. Sili Hyd Cont Mod Lanth Trans Metal Oxid 2014;8(870):372
  • Sullivan B, Schmidt T, Sullivan D. The regents of the university of california, schepens eye research institute, assignees. Ophthalmic Device 2015;8(945):604
  • Winterton L, Novartis AG. Method of making silicone hydrogel contact lenses. USA 2010;7:858
  • Chauhan A, Kim J. University of florida research foundation, incorporated, assignee. Contact Lens Exten Rel Bio Agents Cont Diff Att 2013;8(404):265
  • Peng C, Kim J, Chauhan A. Extended delivery of hydrophilic drugs from silicone-hydrogel contact lenses containing vitamin E diffusion barriers. Biomaterials 2010;31:4032-47
  • Yilmaz T, Aydemir O, Ozercan IH, et al. Effect of viramin e, pentoxifylline and aprotinin on light-induced retinal injury. Ophthalmologica 2007;221:159-66
  • Bilgihan K, Adiguzel U, Sezer C, et al. Effects of topical vitamin E on keratocyte apoptosis after traditional photorefractive keratectomy. Ophthalmologica 2001;215:192-6
  • Samuel N, Kenkare N, Lackey P, et al. assignee. Contact lenses containing carotenoid and method for making same. USA 2014;8(784):867
  • Hsu K, Fentzke RC, Chauhan A. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone-hydrogel contact lenses. Eur J Pharm Biopharm 2013;85:531-40
  • Hsu KH, de la Jara PL, Ariyavidana A, et al. Release of betaine and dexpanthenol from vitamin E modified silicone-hydrogel contact lenses. Curr Eye Res 2015;40(3):267-73
  • Kim J, Peng C, Chauhan A. Extended release of dexamethasone from silicone-hydrogel contact lenses containing vitamin E. J Controlled Release 2010;148:110-16
  • Peng C, Chauhan A. Extended cyclosporine delivery by silicone–hydrogel contact lenses. J Controlled Release 2011;154:267-74
  • Peng CC, Burke M, Chauhan A. Transport of topical anesthetics in vitamin E loaded silicone hydrogel contact lenses. Langmuir 2011;28:1478-87
  • Su X, Kim B, Kim S, et al. Layer-layer-assembled multilayer films for transcutaneous drug and vaccine delivery. ACS Nano 2008;3:3719-29
  • Ochs C, Such G, Yan Y, et al. Biodegradable click capsules with engineered drug-loaded multilayers. ACS Nano 2010;4:1653-63
  • Caruso F, Qiao G, Blencowe A, et al. The University of Melbourne, assignee. Proc Prepar Cross Link Mult Film 2013;8(496):997
  • Ciolino JB, Hudson SP, Mobbs AN, et al. A prototype antifungal contact lens. Invest Ophthalmol Vis Sci 2011;52:6286-91
  • Ciolino J, Hoare T, Kohane D, et al. Massachusetts institute of technology, children’s medical center corporation, massachusetts eye and ear infirmary, assignees. Contact Lens Drug Del Dev 2013;8(414):912
  • Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci 2009;50:3346-52
  • Weiner AL. Pulsatile peri-corneal drug delivery device. WO0184358; 2011
  • Waite S; inventor. Drug delivery from contact lenses with a fluidic module. WO161002; 2014
  • Caldarise SG; inventor. Dynamic fluid zones in contact lenses. WO0242255; 2013
  • Turos E; inventor. Nanoparticles with covalently bound surfactant for drug delivery. WO8414926; 2013
  • Bourlais CL, Acar L, Zia H, et al. Ophthalmic drug delivery systems–recent advances. Prog Retin Eye Res 1998;17:33-58
  • Cho K, Wang X, Nie S, et al. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008;14:1310-16
  • Doshi J, Reneker DH. In: Electrospinning process and applications of electrospun fibers. Industry applications society annual meeting, 1993. Conference record of the 1993 IEEE; 1993. 3:1698-703
  • Buchko CJ, Chen LC, Shen Y, et al. Processing and microstructural characterization of porous biocompatible protein polymer thin films. Polymer (Guildf) 1999;40:7397-407
  • Davis K; inventor. extended release drug-delivery contact lenses and methods of making. WO205252; 2014
  • Nicolson PC, Vogt J. Soft contact lens polymers: An evolution. Biomaterials 2001;22:3273-83
  • Hu H; inventor. Interpenetrating polymer network hydrophilic hydrogels for contact lens. WO0044482; 2001
  • Lim D; inventor. Hydrophilic polymers and contact lenses made therefrom. WO4536554; 1985
  • Levinson DJ; inventor. Microbial cellulose contact lens. WO0039612; 2010
  • Schloss PD, Handelsman J. Status of the microbial census. Microbiol Mol Biol Rev 2004;68:686-91
  • Chow E, Pei Y; inventor. Fast-response photochromic nanostructured contact lenses. WO053633; 2011
  • Kung JS, Sales CS, Manche EE. Corneal sensation and dry eye symptoms after conventional versus inverted side-cut femtosecond LASIK: A prospective randomized study. Ophthalmology 2014;121:2311-16
  • O’Brien T, Jeng P, McDonald M, et al. Acute conjunctivitis: Truth and misconceptions. Curr Med Res Opin 2009;25:1953-61
  • Heller W, Cruz M, Bhagat YR, et al. Gatifloxacin 0.5% administered twice daily for the treatment of acute bacterial conjunctivitis in patients one year of age or older. J Ocul Pharmacol Ther 2014;30:815-22
  • Klein R, Klein BE, Wong TY, et al. The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: The beaver dam eye study. Arch Ophthalmol 2002;120:1551-8
  • Ramos CS; inventor. Therapeutic contact lens for pseudo-aphakic eyes and/or eyes with retinal neuro-degeneration. WO0238703; 2006
  • Lewis SE; inventor. Method of improving vision using contact lenses and corneal collagen crosslinking. WO0318017; 2010
  • Wang LS; inventor. Novel methods and devices for the therapeutic treatment of myopia. WO0364898; 2014
  • Tung H. Contact lens for reshaping the altered corneas of post refractive surgery, previous ortho-K of keratoconus 2006
  • Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: Vision-related quality-of-life differences from a randomized clinical trial. Optom Vis Sci 2005;82:886-91
  • Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol 2009;93:1181-5
  • Lorenz K, Korb C, Herzog N, et al. Tolerability of 24-hour intraocular pressure monitoring of a pressure-sensitive contact lens. J Glaucoma 2013;22:311-16
  • Goedkoop R, Mansouri K, Weinreb R. A minimally invasive device for the monitoring of 24-hour intraocular pressure patterns. US Ophthalmic Rev 2013;10-14
  • Scott M. Novartis joins with google to develop contact lens that monitors blood sugar. The New York Times. 2014;Sect. International Business.
  • Biederman WJ, Otis B; inventors. Google Inc, assignee. Devices and methods for a contact lens with an inward facing light source. USA 2014;8(764):185
  • Baca JT, Finegold DN, Asher SA. Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus. Ocul Surf 2007;5:280-93
  • Product Jurisdiction, 21 C.F.R. § 3.2, 2014
  • Quality System Regulation, C.F.R. § 820.1, 2014
  • FDA. Combination products [Internet]. 2012. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM293277.pdf [Last accessed 4 April 2015]
  • Safety study of a contact lens wtih ketotifen in healthy, normal volunteers by vistakon pharmaceuticals at ClinicalTrials.gov [Internet]. 2011. Available from: http://clinicaltrials.gov/ct2/show/NCT00889252
  • Nomachi M, Sakanishi K, Ichijima H, et al. Evaluation of diminished microbial contamination in handling of a novel daily disposable flat pack contact lens. Eye Contact Lens 2013;39:234-8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.